PMID- 27155073 OWN - NLM STAT- MEDLINE DCOM- 20170808 LR - 20170817 IS - 1874-1754 (Electronic) IS - 0167-5273 (Linking) VI - 216 DP - 2016 Aug 1 TI - Silent myocardial ischemia in asymptomatic patients with type 2 diabetes mellitus without previous histories of cardiovascular disease. PG - 151-5 LID - S0167-5273(16)30683-0 [pii] LID - 10.1016/j.ijcard.2016.04.008 [doi] AB - BACKGROUND: The number of patients with type 2 diabetes mellitus (T2DM) continues to increase all over the world. Cardiovascular disease (CVD), especially coronary artery disease (CAD), is a major cause of the morbidity and mortality in patients with T2DM. The prognosis of patients with silent myocardial ischemia (SMI) is worse than that in those without. METHODS AND RESULTS: Thus, to assess how many patients with SMI existed among those patients, CVD screening tests were performed in 128 asymptomatic patients with T2DM without previous histories of CVD. SMI could be detected in 24 patients (19%) by exercise stress tests and/or the coronary fractional flow reserve. Their 12-lead electrocardiogram and cardiac ultrasonography were both normal. Compared to those without SMI, those with had a statistically significant longer history of T2DM (17+/-1 versus 11+/-1years, p=0.006), and the co-existence of a family history of CVD (42% versus 21%, p=0.037). Furthermore, these factors were demonstrated as independent risk factors of SMI by a multivariate analysis (Odds ratio 1.060 and 4.000, respectively), and in accordance with the disease duration of T2DM, the prevalence of patients with SMI has been increasing (p=0.019). CONCLUSIONS: Physicians should be aware of these conditions when examining patients with T2DM, especially with a family history of CVD and/or long disease duration (>11years) of T2DM, even though they have no symptoms, previous histories of CVDs, and/or abnormal findings on the 12-lead electrocardiogram and cardiac ultrasonography. This may be an effective, safe, and attractive diagnostic strategy for those asymptomatic patients with T2DM. CI - Copyright (c) 2016 Elsevier Ireland Ltd. All rights reserved. FAU - Kawano, Yuki AU - Kawano Y AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Takemoto, Masao AU - Takemoto M AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. Electronic address: matakemo@suikokai.or.jp. FAU - Mito, Takahiro AU - Mito T AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Morisaki, Hiroko AU - Morisaki H AD - Diabetes and Endocrine Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Tanaka, Atsushi AU - Tanaka A AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Sakaki, Yuka AU - Sakaki Y AD - Diabetes and Endocrine Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Matsuo, Atsutoshi AU - Matsuo A AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Abe, Kentaro AU - Abe K AD - Diabetes and Endocrine Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Hida, Satoru AU - Hida S AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Mukae, Kumiko AU - Mukae K AD - Diabetes and Endocrine Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Okazaki, Teiji AU - Okazaki T AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Tayama, Kei-Ichiro AU - Tayama K AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Inoguchi, Toyoshi AU - Inoguchi T AD - Innovation Center for Medical Redox Navigation, Kyushu University, Fukuoka, Japan. FAU - Yoshitake, Kiyonobu AU - Yoshitake K AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. FAU - Kosuga, Ken-Ichi AU - Kosuga K AD - Cardiovascular Center, Munakata Suikokai General Hospital, Fukutsu, Japan. LA - eng PT - Journal Article DEP - 20160411 PL - Netherlands TA - Int J Cardiol JT - International journal of cardiology JID - 8200291 SB - IM MH - Aged MH - Diabetes Mellitus, Type 2/*complications MH - Electrocardiography MH - Exercise Test MH - Female MH - Fractional Flow Reserve, Myocardial MH - Humans MH - Male MH - Myocardial Ischemia/*diagnosis/*epidemiology MH - Odds Ratio MH - Prevalence MH - Prognosis MH - Risk Factors OTO - NOTNLM OT - Asymptomatic OT - Diabetes mellitus OT - Disease duration OT - Family history OT - Silent myocardial ischemia EDAT- 2016/05/08 06:00 MHDA- 2017/08/09 06:00 CRDT- 2016/05/08 06:00 PHST- 2016/03/01 00:00 [received] PHST- 2016/04/02 00:00 [accepted] PHST- 2016/05/08 06:00 [entrez] PHST- 2016/05/08 06:00 [pubmed] PHST- 2017/08/09 06:00 [medline] AID - S0167-5273(16)30683-0 [pii] AID - 10.1016/j.ijcard.2016.04.008 [doi] PST - ppublish SO - Int J Cardiol. 2016 Aug 1;216:151-5. doi: 10.1016/j.ijcard.2016.04.008. Epub 2016 Apr 11.